Feed MHUA
MH

Meihua International Medical Technologies Co., Ltd.

MHUA · NASDAQ

$2.75 -9.84% (-$0.30)
Market Cap $871.0K
P/E Ratio 0.27x
Div. Yield -
ROE 10.49%

Bulios Fair Price

$3.76

36.7% upside

Current Price

$2.75

Undervalued Fair Value Overvalued

According to Bulios Fair Price, MHUA is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
4/9
Valuation
100 /100
Cheap
P/S 0.01x
P/B 0.01x
P/FCF 0.17x
Growth
43 /100
Stable
Rev. growth 9.08%
Book val. growth 32.29%
EPS growth 25.00%
Profitability
50 /100
Moderate
Net margin 10.37%
Op. margin 13.01%
FCF margin 3.23%
Quality
57 /100
Average
ROE 10.49%
ROA 8.58%
Asset turnover 0.83x
Debt
100 /100
Low
Current ratio 5.71x
Int. coverage 42.04x
Net debt/EBITDA -0.18x
Stability
80 /100
Stable
Rev. volatility 9.01%
EPS volatility 50.93%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about MHUA
Online

About the company

Meihua International Medical Technologies (MHUA) is a provider of Class I, II and III disposable medical devices with operating subsidiaries in China. It serve hospitals, pharmacies, medical institutions and medical equipment companies for over 30 years with more than 800 products for domestic sales and 120 products for exports.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

CEO

Lee Leyi

Employees

619

Headquarters

Yangzhou

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.